Cangjie Yang

Cangjie Yang is a highly skilled scientist with several years of research experience focusing on the interaction between glycans and proteins, as well as the development of polymeric nanoplatforms for drug delivery and imaging. They served as a Postdoctoral Research Fellow at Boston College from 2018 to 2021, where they developed glycan-based drugs and mentored students while managing the lab. Currently, as an Investigator II at CSL, Cangjie is involved in lipid nanoparticle development for self-amplifying messenger RNA. They previously completed their PhD at Nanyang Technological University, where they designed new nanoparticle platforms for cancer therapy and imaging, conducting extensive in vitro and in vivo evaluations.